Home
Obi Profile
Fees
Services
News
Publications
Contact
You are here:
Title Details
Search
Login
Composition comprising a HCV NS3 protease inhibitor and a phosphoramidate prodrug of 2'-deoxy-2'-fluoro-2'-C-methyluridine nucleoside
No-Receipt date
2019-03412 - 09/09/2019
No-Filing date
20190402749 - 09/09/2019
No-Granting date
3101145 - 17/10/2019
No-EPO application date
14179358.8 - 26/03/2008
No-EPO granting date
2826784 - 26/06/2019
Gazette No-Publication date of application
-
Gazette No-Publication date of granted patent
10/2019 - 28/11/2019
Expiration date
27/03/2028
Kind of title
Validation of European Patent
Legal status
VALID
Priorities
US909315 P30/03/2007/US
US982309 P24/10/2007/US
US5301521/03/2008/US
Active Substance of Supplementary Certificates
-
IPC Classification
Ipc Class
C07H 19/20
A61P 31/00
A61K 31/7072
Related Documents
Related Titles
Owners
Code
Firstname
Surname
Address
Town
ZIP
Country
1062239
GILEAD PHARMASSET LLC
C/O GILEAD SCIENCES, INC. 333 LAKESIDE DRIVE
FOSTER CITY, CA 94404
UNITED STATES OF AMERICA (USA)
Inventors
Code
Firstname
Surname
2677517
DU, JINFA
2677518
WANG, PEIYUAN
2677519
NAGARATHNAM, DHANAPALAN
2677520
SOFIA, MICHAEL JOSEPH
Representatives
Code
Firstname
Surname
Address
Town
Zip
3190
KONSTANTINOS
KILIMIRIS "PATRINOS & KILIMIRIS DIKIGORIKI ETAIRIA"
CHATZIGIANNI MEXI 7
ATHINA (ATTIKIS)
11528
Contact
Code
Firstname
Surname
Address
Town
Zip
Country
8149
KONSTANTINOS
KILIMIRIS
CHATZIGIANNI MEXI 7
ATHINA (ATTIKIS)
11528
GREECE
Owners History
Title Instruments
Payments history
18 renewals have been done
© OBI all rights reserved
designed & developed by PROFILE S.A.
Certified QMS :
EN ISO 9001:2015
and
ΕΝ ISO 14001:2015
The project "Internet technological information diffusion from industrial property titles" is co-financed 70% by the European Regional Development Found and 30% by the Hellenic public sector (Operational programme "Competitiveness", Measure 4.4).